CRIS Current Research Information System

MONTANARO, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.805
EU - Europa 3.145
AS - Asia 2.950
AF - Africa 191
SA - Sud America 167
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.269
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.769
SG - Singapore 945
CN - Cina 880
IT - Italia 787
GB - Regno Unito 754
VN - Vietnam 483
DE - Germania 411
SE - Svezia 292
UA - Ucraina 261
HK - Hong Kong 239
RU - Federazione Russa 165
IN - India 160
BR - Brasile 124
FR - Francia 124
IE - Irlanda 105
KR - Corea 84
JP - Giappone 78
CI - Costa d'Avorio 63
ZA - Sudafrica 59
NL - Olanda 55
EE - Estonia 37
TG - Togo 31
BE - Belgio 30
FI - Finlandia 29
JO - Giordania 29
AR - Argentina 22
CA - Canada 20
GR - Grecia 19
SC - Seychelles 18
AT - Austria 16
NG - Nigeria 15
ID - Indonesia 13
CH - Svizzera 11
AU - Australia 10
MX - Messico 10
HR - Croazia 9
TR - Turchia 8
PL - Polonia 7
EC - Ecuador 6
IR - Iran 6
LT - Lituania 6
CL - Cile 5
ES - Italia 5
RO - Romania 5
AL - Albania 4
BG - Bulgaria 4
CO - Colombia 4
PK - Pakistan 4
PY - Paraguay 4
BD - Bangladesh 3
CZ - Repubblica Ceca 3
LB - Libano 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.269
Salva come PNG Salva come JPEG
Città #
Southend 656
Singapore 608
Santa Clara 344
Chandler 339
Ashburn 321
Fairfield 292
Dong Ket 239
Hong Kong 239
Hefei 206
Jacksonville 199
Princeton 183
Wilmington 170
Woodbridge 137
Ann Arbor 135
Seattle 131
Houston 129
Dublin 105
Beijing 98
Dallas 92
Cambridge 91
Boardman 84
Seoul 84
Los Angeles 76
Tokyo 74
Padova 69
Westminster 68
Abidjan 63
Nanjing 60
Bologna 58
Mülheim 45
Ho Chi Minh City 41
Berlin 39
Bremen 39
Milan 39
Rome 39
Buffalo 36
Medford 36
Saint Petersburg 35
Shenyang 33
Lomé 31
Amman 29
Brussels 29
San Diego 26
San Venanzo 26
Hebei 25
Helsinki 24
Hanoi 22
Jinan 22
Munich 22
Nanchang 22
New York 21
Jiaxing 19
Redondo Beach 19
Changsha 18
Mahé 17
Shanghai 15
Zhengzhou 15
Dearborn 14
Guangzhou 14
Olalla 14
Palermo 14
Abeokuta 13
Bengaluru 13
Florence 13
Frankfurt am Main 13
Tianjin 13
London 11
Verona 11
Fuzhou 10
Ningbo 10
Norwalk 10
São Paulo 10
Falkenstein 9
Falls Church 9
Kunming 9
Nuremberg 9
Phoenix 9
Wuhan 9
Bühl 8
Ferrero 8
Haikou 8
Hangzhou 8
Lanzhou 8
Modena 8
Shenzhen 8
Turin 8
Yubileyny 8
Atlanta 7
Cesena 7
Chicago 7
Montesilvano Marina 7
Ottawa 7
Rio de Janeiro 7
Torino 7
Brooklyn 6
Chennai 6
Parma 6
Pescara 6
Redwood City 6
San Francisco 6
Totale 6.528
Salva come PNG Salva come JPEG
Nome #
Leucoencefalopatia Multifocale Progressiva: complicanza dell'immunosoppressione o reazione avversa da farmaci? 519
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 239
Le basi della farmacologia 209
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 200
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 198
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 194
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions 193
A 3 year survey on the use of antibacterial agents in five Italian hospitals. 188
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 174
An update on the first decade of the European centralized procedure: how many innovative drugs? 174
An approach to evaluate appropriateness in the antibacterial therapy in Italian hospitals. 169
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 168
Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature 168
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. 164
Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). 160
Changes in prevalence and pattern of drug use in a ten years period in Italy. 8th Congress of the European Association for Clinical Pharmacology and Therapeutics 158
Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database 145
A 5 years surveillance of antibiotic use and microbiological resistance in an Italian university hospital. 144
Hepatic adverse drug reactions: a case/non-case study in Italy 142
Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug’s safety profile. 140
Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). 139
Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy 138
Antibiotic use in Italian hospitals 2002-2004. 136
Developing a Method To Identify Prescribing Profiles of Antihypertensive Drugs in General Practice. 135
Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy 135
Ticlopidine Safety Profile: A Case/Non-Case Study on the Basis of the Spontaneous ADRs Reporting in Italy 134
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database 133
Gastro-intestinal problems and concomitant medication in NSAID users: additional findings from a questionnaire-based survey in Italy 133
Pattern of NSAID use in the Italian general population: a questionnaire-based survey. 133
Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations 133
Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data 132
The adherence to antihypertensive treatments: an Italian survey by using prescription databases. 132
Initial treatment of hypertension and adherence to therapy in general practice in Italy 132
Cardiovascular events in statin recipients: a 3-year record-linkage study on prescription and hospital discharge databases 129
Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database 127
Therapeutic innovation of the drugs approved by the EMEA-centralised procedure 126
Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara. 126
Un commento alla lettera sulla definizione di farmaco innovativo 126
Antibiotic Use and Microbiological Surveillance: An Ecological Study in an Italian University Hospital. 124
Safety profile of thiazolidinediones on the basis of the FDA-AERS database: cardiovascular and bone fracture risks for rosiglitazone and pioglitazone 124
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations 123
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy 121
Analyses of natalizumab prescriptions and discontinuations in multiple sclerosis patients of an Italian region 119
Risk-management of natalizumab: a drug utilization study on duration of therapy and cause of discontinuation in Emilia-Romagna region 118
Progressive Multifocal Leukoencephalopathy: an effect of immunodeficiency or an adverse drug reaction? 117
Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database 115
The Influence of Notoriety Bias on ADR Spontaneous Reporting Rate. 115
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. 114
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures 113
Triptans and serious cardiovascular events: possible safety signals from the FDA Adverse Event Reporting System database 112
Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine 111
Pattern of Triptan Use in a Sample of the Italian General Population 110
The pharmacovigilance program on natalizumab in Italy: 2 years of experience 110
Progetto europeo di confronto dell'uso dei farmaci 109
Assessing the risk of Osteonecrosis of the Jaw (ONJ) due to Bisphosphonates (BP) therapy in the secondary prevention of osteoporotic fractures, 109
Three years of experience: the Italian registry and safety data update 105
Natalizumab: a country-based surveillance program 105
Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System 104
La rimborsabilità di memantina - il trilemma di Münchausen 104
Prevenire gli errori in terapia. Strategie per i farmacisti 104
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System 100
Progressive Multifocal Leukoencephalopathy (PML): only immunosuppressive complication or also drug adverse reaction? 98
Farmaci EMEA ed innovazione terapeutica 96
Progetto di monitoraggio della prescrizione di farmaci disease-modifying nella sclerosi multipla in Emilia-Romagna 96
Ticlopidine’s safety profile: a case/non case study on the basis of the spontaneous ADR reporting in Italy. 95
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice 94
Hepatic adverse drug reactions: analysis of an italian spontaneous reporting database. 92
The Italian Surveillance Program on Natalizumab 88
Monitoring disease-modifying drugs in multiple sclerosis in Emilia Romagna 88
La medicina basata sulle prove - Istruzioni per l'uso. Prima edizione italiana 87
Monitoring the use of disease-modifying drugs in multiple sclerosis 87
Pattern of use of NSAIDs in the Italian general population: a questionnaire-based study 85
The Italian Natalizumab Registry: a 1-year follow-up 82
Prescrizione di Entacapone nella Regione Emilia-Romagna 81
Removal of the EMA orphan designation upon request of the sponsor: cui prodest? 79
La medicina basata sulle prove. Dalle fonti di conoscenza alla realtà del singolo paziente. Seconda edizione 73
Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database 59
On criteria to evaluate the therapeutic innovation of drugs 56
Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data 50
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance data 47
Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis 42
Overview of Orphan Medicines in European Union: An Analysis of Regulatory and Technical-Scientific Aspects 22
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: An overview 22
Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab 22
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: An analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions 3
Use of anti-asthmatic drugs in Italy: Analysis of prescriptions in general practice in the light of guidelines for asthma treatment 2
Totale 10.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021625 0 0 0 0 0 54 6 62 59 34 67 343
2021/20221.412 184 49 62 98 120 66 25 93 51 91 355 218
2022/20231.483 159 183 100 203 99 128 28 86 261 45 127 64
2023/2024498 46 69 37 60 42 43 32 42 22 39 50 16
2024/20251.731 69 230 143 86 440 132 87 52 30 55 81 326
2025/20261.975 240 370 408 340 502 115 0 0 0 0 0 0
Totale 10.457